PA-517 Updated safety and efficacy results for linvoseltamab (LINVO) in patients (pts) with high-risk smoldering multiple myeloma (HR-SMM): Phase 2 LINKER-SMM1 trial
Year: 2026
Type: conference-abstract
Authors: Paula Rodríguez-Otero, Neus Amer Salas, María Esther Clavero, Paz Ribas, María del Carmen Martínez-Chamorro, Anna Sureda, Albert Oriol, Laura Rosiñol, Diego Conde-Royo, Bruno Paiva, Jacob Glass, Anju Shrestha, Quang Nguyen, Anita Boyapati, Anasuya Hazra, Glenn S. Kroog, Shawn M. Sarkaria, Jesús San-Miguel, María-Victoria Mateos
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7213862588